Form 4 for SAM BOSTON BEER CO INC
Accepted 2023-03-02 00:00:00 ET · period of report 2023-03-01 · accession 0001562180-23-002112 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-02 | 2023-03-01 | SAM | Smalla Frank H. | CFO | F - Tax | $323.80 | -196 | 15.7K | -1% | -$63.5K |
| D | 2023-03-02 | 2023-03-01 | SAM | Smalla Frank H. | CFO | A - Grant | $0.00 | +1,545 | 17.2K | +10% | $0 |
| DM | 2023-03-02 | 2023-03-01 | SAM | Smalla Frank H. | CFO | A - Grant | $0.00 | +4,557 | 1,911 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common | 2023-03-01 | F | D | 196 | $323.80 | 15,653 | D | — | — | |
| 2 | Common | Class A Common | 2023-03-01 | A | A | 1,545 | $0.00 | 17,198 | D | — | — | (F3) The shares reported include 10,639 shares of restricted stock subject to vesting conditions. |
| 3 | Derivative | March 1, 2021 Stock Option | 2023-03-01 | A | A | 208 | $0.00 | 625 | D | $1,028.71 · 2023-03-01 to 2031-02-28 | 625 Class A Common | (F6) The Performance-Based Stock Options were granted pursuant to the Issuer's EEIP on March 1, 2021. The extent to which the options were exercisable was dependent upon the Company achieving certain compounded annual growth rate targets based on net revenue growth in Fiscal Year 2022 over Fiscal Year 2020. In February 2023, the Compensation Committee determined that the performance criteria had been achieved, and as such the options vest in three equal installments on March 1 in the years 2023-2025, provided that the Reporting Person remains employed by the Company on the applicable vesting dates, and subject to accelerated vesting in certain situations. |
| 4 | Derivative | March 1, 2023 Stock Option | 2023-03-01 | A | A | 3,084 | $0.00 | 3,084 | D | $323.80 · 2025-03-01 to 2033-02-28 | 3,084 Class A Common | (F7) The Performance-Based Stock Options were granted pursuant to the Issuer's EEIP on March 1, 2023. The extent to which the options become exercisable is dependent upon the Company achieving certain compounded annual growth rate targets based on net revenue growth in Fiscal Year 2024 over Fiscal Year 2022. The Compensation Committee will determine if the performance criteria have been achieved prior to March 1, 2025. If the performance criteria is achieved, the options vest in three equal installments on March 1 in the years 2025-2027, provided that the Reporting Person remains employed by the Company on the applicable vesting dates, and subject to accelerated vesting in certain situations. |
| 5 | Derivative | March 1, 2020 Stock Option | 2023-03-01 | A | A | 628 | $0.00 | 1,883 | D | $370.79 · 2022-03-01 to 2030-02-28 | 1,883 Class A Common | (F5) The Performance-Based Stock Options were granted pursuant to the Issuer's EEIP on March 1, 2020. The extent to which the options were exercisable was dependent upon the Company achieving certain compounded annual growth rate targets based on net revenue growth in Fiscal Year 2021 over Fiscal Year 2019. In February 2022, the Compensation Committee determined that the performance criteria had been achieved, and as such the options vest in three equal installments on March 1 in the years 2022-2024, provided that the Reporting Person remains employed by the Company on the applicable vesting dates, and subject to accelerated vesting in certain situations. |
| 6 | Derivative | March 1, 2019 Stock Option | 2023-03-01 | A | A | 637 | $0.00 | 1,911 | D | $312.56 · 2021-03-01 to 2029-02-28 | 1,911 Class A Common | (F4) The Performance-Based Stock Options were granted pursuant to the Issuer's EEIP on March 1, 2019. The extent to which the options were exercisable was dependent upon the Company achieving certain compounded annual growth rate targets based on net revenue growth in Fiscal Year 2020 over Fiscal Year 2018. In February 2021, the Compensation Committee determined that the performance criteria had been achieved, and as such the options vested in three equal installments on March 1 in the years 2021-2023. |